← Open Payments lookup

MONIQUE DYE: Open Payments

NPI 1962153064 · SAN LUIS OBISPO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$791 in 26 payments from 8 companies in 2025. Trend: 2023 $309 · 2024 $408 · 2025 $791

Food & beverage: $791
CompanyPaymentsAmount
REVANCE THERAPEUTICS, INC.4$261
GlaxoSmithKline, LLC.11$198
Novo Nordisk Inc2$146
ABBVIE INC.3$50
PFIZER INC.2$49
Boehringer Ingelheim Pharmaceuticals, Inc.2$46
Astellas Pharma US Inc1$22
Merck Sharp & Dohme LLC1$18

Products named: DAXXIFY, TRELEGY ELLIPTA, Ozempic, PREVNAR 20, JARDIANCE, QULIPTA, SHINGRIX, Veozah.

Industry payments across CA — which companies pay providers there.